Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin. Guan T, Lo M, Young R, Ai W, et al. Leuk Lymphoma 2022 Jul 25:1-4. doi: 10.1080/10428194.2022.2100369.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guan T, Lo M, Young R, Ai W, et al. Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin. Leuk Lymphoma 2022 Jul 25:1-4. doi: 10.1080/10428194.2022.2100369.
PMID: 35875857